AB Science S.A.
ABSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $61 | $46 | $130 | $0 |
| - Cash | $5 | $8 | $9 | $6 |
| + Debt | $19 | $18 | $19 | $19 |
| Enterprise Value | $76 | $56 | $140 | $13 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 0.6% | -8.6% | 7.3% | – |
| Gross Profit | $0 | $1 | $0 | $0 |
| % Margin | 29.3% | 152.5% | 83.4% | 68.6% |
| EBITDA | -$3 | -$2 | -$3 | -$5 |
| % Margin | -490.5% | -379.3% | -604.1% | -971.8% |
| Net Income | -$5 | -$3 | -$4 | -$2 |
| % Margin | -1,005.2% | -656.6% | -798% | -301.5% |
| EPS Diluted | -0.09 | -0.064 | -0.087 | -0.03 |
| % Growth | -41.1% | 26.2% | -184.5% | – |
| Operating Cash Flow | -$4 | -$3 | $3 | -$8 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$3 | $3 | -$8 |